Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022

SELL
$6.71 - $12.55 $335 - $627
-50 Reduced 50.0%
50 $0
Q2 2021

Jul 26, 2021

SELL
$2.94 - $6.79 $1,176 - $2,716
-400 Reduced 80.0%
100 $0
Q1 2020

Apr 17, 2020

SELL
$2.08 - $5.41 $2,080 - $5,410
-1,000 Reduced 66.67%
500 $1,000
Q3 2019

Oct 09, 2019

BUY
$3.95 - $5.72 $5,925 - $8,580
1,500 New
1,500 $7,000

Others Institutions Holding ENOB

About Enochian Biosciences Inc


  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Ellis Investment Partners, LLC Portfolio

Follow Ellis Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ellis Investment Partners, LLC with notifications on news.